Blog

Ahmed M, Zaghloul N, Zimmerman P, Casanova NG, Sun X, Reyes Hernon V, et al. Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb. Pulm Circ. 2021;11(4):20458940211059712.

PubMed 
PubMed Central 

Google Scholar 

Chen J, Sysol JR, Singla S, Zhao S, Yamamura A, Valdez-Jasso D, et al. Nicotinamide phosphoribosyltransferase promotes pulmonary vascular remodeling and is a therapeutic target in pulmonary arterial hypertension. Circulation. 2017;135(16):1532–46.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Sun X, Sun BL, Babicheva A, Vanderpool R, Oita RC, Casanova N, et al. Direct extracellular NAMPT involvement in pulmonary hypertension and vascular remodeling. Transcriptional regulation by SOX and HIF-2alpha. Am J Respir Cell Mol Biol. 2020;63(1):92–103.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Antioxid Redox Signal. 2021;34(12):891–914.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Pillai VB, Sundaresan NR, Kim G, Samant S, Moreno-Vinasco L, Garcia JG, et al. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling. Am J Physiol Heart Circ Physiol. 2013;304(3):H415-26.

CAS 
PubMed 

Google Scholar 

Oita RC, Camp SM, Ma W, Ceco E, Harbeck M, Singleton P, et al. Novel mechanism for nicotinamide phosphoribosyltransferase Inhibition of TNF-alpha-mediated apoptosis in human lung endothelial cells. Am J Respir Cell Mol Biol. 2018;59(1):36–44.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Casanova NG, Herazo-Maya J, Kempf CL, Sun BL, Song JH, Hernandez A et al. eNAMPT is a novel DAMP and therapeutic target in human and murine pulmonary fibrosis. . Am J Respir Cell Mol Biol. 2025.

Quijada H, Bermudez T, Kempf CL, Valera DG, Garcia AN, Camp SM et al. Endothelial eNAMPT amplifies preclinical acute lung injury: efficacy of an eNAMPT-Neutralising mAb. Eur Respir J. 2021;57(5):2002536.

Bao C, Liang S, Han Y, Yang Z, Liu S, Sun Y, et al. The novel lysosomal autophagy inhibitor (ROC-325) ameliorates experimental pulmonary hypertension. Hypertension. 2023;80(1):70–83.

CAS 
PubMed 

Google Scholar 

Tang C, Luo Y, Li S, Huang B, Xu S, Li L. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats. Biomed Pharmacother. 2021;133:111081.

CAS 
PubMed 

Google Scholar 

Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, et al. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics. 2008;33(2):278–91.

CAS 
PubMed 

Google Scholar 

Tang H, Babicheva A, McDermott KM, Gu Y, Ayon RJ, Song S, et al. Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am J Physiol Lung Cell Mol Physiol. 2018;314(2):L256–75.

PubMed 

Google Scholar 

Guo M, Morley MP, Jiang C, Wu Y, Li G, Du Y, et al. Guided construction of single cell reference for human and mouse lung. Nat Commun. 2023;14(1):4566.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Tsukui T, Sun KH, Wetter JB, Wilson-Kanamori JR, Hazelwood LA, Henderson NC, et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat Commun. 2020;11(1):1920.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, stringtie and ballgown. Nat Protoc. 2016;11(9):1650–67.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Miller SA, Policastro RA, Sriramkumar S, Lai T, Huntington TD, Ladaika CA, et al. LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF-mutant colorectal cancer. Cancer Res. 2021;81(14):3791–805.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Gillich A, Zhang F, Farmer CG, Travaglini KJ, Tan SY, Gu M, et al. Capillary cell-type specialization in the alveolus. Nature. 2020;586(7831):785–9.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu B, Yi D, Xia X, Ramirez K, Zhao H, Cao Y, et al. General capillary endothelial cells undergo reprogramming into arterial endothelial cells in pulmonary hypertension through HIF-2alpha/Notch4 pathway. Circulation. 2024;150(5):414–7.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Man S, Sanchez Duffhues G, Ten Dijke P, Baker D. The therapeutic potential of targeting the endothelial-to-mesenchymal transition. Angiogenesis. 2019;22(1):3–13.

CAS 
PubMed 

Google Scholar 

Hong J, Arneson D, Umar S, Ruffenach G, Cunningham CM, Ahn IS, et al. Single-cell study of two rat models of pulmonary arterial hypertension reveals connections to human pathobiology and drug repositioning. Am J Respir Crit Care Med. 2021;203(8):1006–22.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Tarhan L, Bistline J, Chang J, Galloway B, Hanna E, Weitz E. Single cell portal: an interactive home for single-cell genomics data. bioRxiv. 2023. https://doi.org/10.1101/2023.07.13.548886.

Article 
PubMed 
PubMed Central 

Google Scholar 

Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165–75.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Ahmed M, Casanova NG, Zaghloul N, Gupta A, Rodriguez M, Robbins IR, et al. The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes. Front Physiol. 2023;14:1129413.

PubMed 
PubMed Central 

Google Scholar 

Bime C, Casanova NG, Nikolich-Zugich J, Knox KS, Camp SM, Garcia JGN. Strategies to dampen COVID-19-mediated lung and systemic inflammation and vascular injury. Transl Res. 2021;232:374–8. https://doi.org/10.1016/j.trsl.2020.12.008.

Gao L, Ramirez FJ, Cabrera JTO, Varghese MV, Watanabe M, Tsuji-Hosokawa A, et al. eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes. Diabetologia. 2024;67(9):1998–2011.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Sun BL, Sun X, Casanova N, Garcia AN, Oita R, Algotar AM, et al. Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: novel biomarker and therapeutic target. EBioMedicine. 2020;61:103059.

PubMed 
PubMed Central 

Google Scholar 

Sun BL, Sun X, Kempf CL, Song JH, Casanova NG, Camp SM, et al. Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis. FASEB J. 2023;37(3):e22825.

CAS 
PubMed 

Google Scholar 

Tumurkhuu G, Casanova NG, Kempf CL, Ercan Laguna D, Camp SM, Dagvadorj J, et al. eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE lung vasculitis and alveolar hemorrhage. J Transl Autoimmun. 2023;6:100181.

CAS 
PubMed 

Google Scholar 

Ye SQ, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med. 2005;171(4):361–70.

PubMed 

Google Scholar 

Alvandi Z, Bischoff J. Endothelial-mesenchymal transition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2357–69.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Huang J, Pu Y, Zhang H, Xie L, He L, Zhang CL, et al. KLF2 mediates the suppressive effect of laminar flow on vascular calcification by inhibiting endothelial BMP/SMAD1/5 signaling. Circ Res. 2021;129(4):e87-100.

CAS 
PubMed 

Google Scholar 

Kang K, Xiang J, Zhang X, Xie Y, Zhou M, Zeng L, et al. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. Cell Mol Biol Lett. 2024;29(1):69.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhang-Sun ZY, Xu XZ, Escames G, Lei WR, Zhao L, Zhou YZ, et al. Targeting NR1D1 in organ injury: challenges and prospects. Mil Med Res. 2023;10(1):62.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Chae WJ, Bothwell ALM. Canonical and non-canonical Wnt signaling in immune cells. Trends Immunol. 2018;39(10):830–47.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Sun L, Xing J, Zhou X, Song X, Gao S. Wnt/beta-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells. Biomed Pharmacother. 2024;175:116685.

CAS 
PubMed 

Google Scholar 

Tang H, Wu K, Wang J, Vinjamuri S, Gu Y, Song S, et al. Pathogenic role of mTORC1 and mTORC2 in pulmonary hypertension. JACC Basic Transl Sci. 2018;3(6):744–62.

PubMed 
PubMed Central 

Google Scholar 

Lowe M, Lage J, Paatela E, Munson D, Hostager R, Yuan C, et al. Cry2 is critical for circadian regulation of myogenic differentiation by Bclaf1-mediated mRNA stabilization of Cyclin D1 and Tmem176b. Cell Rep. 2018;22(8):2118–32.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Bryant AJ, Ebrahimi E, Nguyen A, Wolff CA, Gumz ML, Liu AC, Esser KA. A wrinkle in time: circadian biology in pulmonary vascular health and disease. Am J Physiol Lung Cell Mol Physiol. 2022;322(1):L84–101.

CAS 
PubMed 

Google Scholar 

Lopez-Moncada F, Torres MJ, Lavanderos B, Cerda O, Castellon EA, Contreras HR. SPARC induces E-Cadherin repression and enhances cell migration through integrin alphavbeta3 and the transcription factor ZEB1 in prostate cancer cells. Int J Mol Sci. 2022;23(11):5874. https://doi.org/10.3390/ijms23115874.

Dean A, Gregorc T, Docherty CK, Harvey KY, Nilsen M, Morrell NW, et al. Role of the aryl hydrocarbon receptor in Sugen 5416-induced experimental pulmonary hypertension. Am J Respir Cell Mol Biol. 2018;58(3):320–30.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Liang S, Guo H, Ma K, Li X, Wu D, Wang Y, et al. A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression. Cancer Res. 2021;81(23):5889–903.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Karoor V, Fini MA, Loomis Z, Sullivan T, Hersh LB, Gerasimovskaya E, et al. Sustained activation of Rho GTPases promotes a synthetic pulmonary artery smooth muscle cell phenotype in Neprilysin null mice. Arterioscler Thromb Vasc Biol. 2018;38(1):154–63.

CAS 
PubMed 

Google Scholar 

Alexander MR, Murgai M, Moehle CW, Owens GK. Interleukin-1beta modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-kappaB-dependent mechanisms. Physiol Genomics. 2012;44(7):417–29.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Cho DI, Ahn MJ, Cho HH, Cho M, Jun JH, Kang BG, et al. Angptl4 stabilizes atherosclerotic plaques and modulates the phenotypic transition of vascular smooth muscle cells through KLF4 downregulation. Exp Mol Med. 2023;55(2):426–42.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Cheung AK, Ko JM, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, et al. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci U S A. 2011;108(20):8390–5.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Yang L, Zhou F, Zheng D, Wang D, Li X, Zhao C, Huang X. FGF/FGFR signaling: from lung development to respiratory diseases. Cytokine Growth Factor Rev. 2021;62:94–104.

CAS 
PubMed 

Google Scholar 

Wen Z, Jiang L, Yu F, Xu X, Chen M, Li C, et al. ScrNA-seq reveals NAMPT-mediated macrophage polarization shapes smooth muscle cell plasticity in pulmonary arterial hypertension. Interdiscip Med. 2024;2(4):e20240016.

CAS 

Google Scholar 

Streef TJ, Groeneveld EJ, van Herwaarden T, Hjortnaes J, Goumans MJ, Smits AM. Single-cell analysis of human fetal epicardium reveals its cellular composition and identifies CRIP1 as a modulator of EMT. Stem Cell Reports. 2023;18(7):1421–35.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Ahmed MN, Zhang Y, Codipilly C, Zaghloul N, Patel D, Wolin M, Miller EJ. Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension. Mol Med. 2012;18:38–46.

CAS 
PubMed 

Google Scholar 

Tarazona S, Furio-Tari P, Turra D, Pietro AD, Nueda MJ, Ferrer A, et al. Data quality aware analysis of differential expression in RNA-seq with NOIseq r/bioc package. Nucleic Acids Res. 2015;43(21):e140.

PubMed 
PubMed Central 

Google Scholar 

Zawia A, Arnold ND, West L, Pickworth JA, Turton H, Iremonger J, et al. Altered macrophage polarization induces experimental pulmonary hypertension and is observed in patients with pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol. 2021;41(1):430–45.

CAS 
PubMed 

Google Scholar 

Qiu H, He Y, Ouyang F, Jiang P, Guo S, Guo Y. The role of regulatory T cells in pulmonary arterial hypertension. J Am Heart Assoc. 2019;8(23):e014201.

PubMed 
PubMed Central 

Google Scholar 

Rodriguez M, Xu H, Hernandez A, Ingraham J, Canizales Galaviz J, Teran Arce F et al. NEDD4 E3 ligase-catalyzed NAMPT ubiquitination and autophagy are essential for pyroptosis-independent NAMPT secretion in human monocytes. Cell Commun Signal. 2025;23:157 https://doi.org/10.1186/s12964-025-02164-5.

Audrito V, Serra S, Brusa D, Mazzola F, Arruga F, Vaisitti T, et al. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood. 2015;125(1):111–23.

CAS 
PubMed 

Google Scholar 

Wang Z, Li W, Chen S, Tang XX. Role of ADAM and ADAMTS proteases in pathological tissue remodeling. Cell Death Discov. 2023;9(1):447.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Hudalla H, Michael Z, Christodoulou N, Willis GR, Fernandez-Gonzalez A, Filatava EJ, et al. Carbonic anhydrase inhibition ameliorates inflammation and experimental pulmonary hypertension. Am J Respir Cell Mol Biol. 2019;61(4):512–24.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhu Y, Dun H, Ye L, Terada Y, Shriver LP, Patti GJ et al. Targeting fatty acid beta-oxidation impairs monocyte differentiation and prolongs heart allograft survival. JCI Insight. 2022;7(7):e151596. https://doi.org/10.1172/jci.insight.151596.

Tyrrell C, De Cecco M, Reynolds NL, Kilanowski F, Campopiano D, Barran P, et al. Isoleucine/leucine2 is essential for chemoattractant activity of beta-defensin Defb14 through chemokine receptor 6. Mol Immunol. 2010;47(6):1378–82.

CAS 
PubMed 

Google Scholar 

Cai X, Deng J, Ming Q, Cai H, Chen Z. Chemokine-like factor 1: a promising therapeutic target in human diseases. Exp Biol Med (Maywood). 2020;245(16):1518–28.

CAS 
PubMed 

Google Scholar 

Liao Y, Deng C, Wang X. VSIG4 ameliorates intestinal inflammation through inhibiting macrophages NLRP3 inflammasome and pyroptosis. Tissue Cell. 2024;86:102285.

CAS 
PubMed 

Google Scholar 

Li R, Chen B, Kubota A, Hanna A, Humeres C, Hernandez SC, et al. Protective effects of macrophage-specific integrin alpha5 in myocardial infarction are associated with accentuated angiogenesis. Nat Commun. 2023;14(1):7555.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Jairath V, Acosta Felquer ML, Cho RJ. IL-23 inhibition for chronic inflammatory disease. Lancet. 2024;404(10463):1679–92.

CAS 
PubMed 

Google Scholar 

Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135(2):112–24.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Garcia AN, Casanova NG, Valera DG, Sun X, Song JH, Kempf CL, et al. Involvement of eNAMPT/TLR4 signaling in murine radiation pneumonitis: protection by eNAMPT neutralization. Transl Res. 2022;239:44–57.

CAS 
PubMed 

Google Scholar 

Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol. 2009;54(1 Suppl):S10–9.

CAS 
PubMed 

Google Scholar 

Pullamsetti SS, Savai R, Janssen W, Dahal BK, Seeger W, Grimminger F, et al. Inflammation, immunological reaction and role of infection in pulmonary hypertension. Clin Microbiol Infect. 2011;17(1):7–14.

CAS 
PubMed 

Google Scholar 

Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122(9):920–7.

CAS 
PubMed 

Google Scholar 

Wang J, Tian XT, Peng Z, Li WQ, Cao YY, Li Y, Li XH. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling. Vascul Pharmacol. 2019;117:35–44.

CAS 
PubMed 

Google Scholar 

Xiao G, Zhuang W, Wang T, Lian G, Luo L, Ye C, et al. Transcriptomic analysis identifies toll-like and nod-like pathways and necroptosis in pulmonary arterial hypertension. J Cell Mol Med. 2020;24(19):11409–21.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Young KC, Hussein SM, Dadiz R, deMello D, Devia C, Hehre D, et al. Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension. Exp Lung Res. 2010;36(2):111–9.

CAS 
PubMed 

Google Scholar 

Dai Z, Li M, Wharton J, Zhu MM, Zhao YY. Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2alpha. Circulation. 2016;133(24):2447–58.

CAS 
PubMed 
PubMed Central 

Google Scholar